Compugen (CGEN) EBT Margin (2009 - 2026)

Compugen's (CGEN) quarterly EBT Margin came in at 352.21% in Q1 2026, up 3916.0% year-on-year from 8.77% in Q1 2025, and up 317.18% quarter-over-quarter from 84.42% in Q4 2025.

Compugen (CGEN) EBT Margin (2009 - 2026) Analysis & Trends

Compugen has disclosed EBT Margin across 15 years of filings, most recently posting 352.21% for Q1 2026.

  • EBT Margin for Q1 2026 came in at 352.21%, up 3916.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 49.43% (up 8503.0% YoY), and the FY2025 annual result was 48.65%, up 8349.0% from the prior year.
  • EBT Margin came in at 352.21% for Q1 2026 at Compugen, up from 84.42% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 352.21% in Q1 2026 to a low of 1723.07% in Q2 2025.
  • The 5-year median for EBT Margin is 33.74% (2024), against an average of 151.92%.
  • Peak annual rise in EBT Margin reached 49999 bps in 2025, while the deepest fall reached 147479 bps in 2025.
  • Compugen's EBT Margin stood at 40.45% in 2022, then surged by 238 bps to 55.95% in 2023, then tumbled by 843 bps to 415.57% in 2024, then soared by 120 bps to 84.42% in 2025, then soared by 317 bps to 352.21% in 2026.
  • The last three EBT Margin figures came in at 352.21% (Q1 2026), 84.42% (Q4 2025), and 366.95% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Compugen 189.59 Mn 97.83 Mn 352,000.00 352.21%

Historic Data

Download Data
DateValue
Mar 31, 2026 352.21%
Dec 31, 2025 84.42%
Sep 30, 2025 -366.95%
Jun 30, 2025 -1,723.07%
Mar 31, 2025 313.05%
Dec 31, 2024 -415.57%
Sep 30, 2024 33.74%
Jun 30, 2024 -248.28%
Mar 31, 2024 283.86%
Dec 31, 2023 55.95%
Dec 31, 2022 -40.45%
Sep 30, 2021 -102.60%
Dec 31, 2020 -428.15%
Sep 30, 2018 -39.88%
Mar 31, 2018 1.04%
Dec 31, 2016 -0.02%
Sep 30, 2016 -11,115.71%
Jun 30, 2016 -1,333.06%
Mar 31, 2016 -9,538.71%
Dec 31, 2015 -0.99%